Predictors of early response to onabotulinumtoxin type a in chronic migraine

被引：0
|
作者：
Mas-Sala, N. [1 ]
Quintana, M. [1 ]
Alvarez-Sabin, J. [1 ]
Pozo-Rosich, P. [1 ]
机构：
[1] Hosp Univ Vall Hebron, Neurol, Barcelona, Spain
来源：
JOURNAL OF HEADACHE AND PAIN | 2014年 / 15卷
关键词：
Migraine; Early Response; Chronic Migraine; Headache Frequency; Episodic Migraine;
D O I：
10.1186/1129-2377-15-S1-G31
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EHMTI-0283
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data
    Ornello, Raffaele
    Guerzoni, Simona
    Baraldi, Carlo
    Evangelista, Luana
    Frattale, Ilaria
    Marini, Carmine
    Tiseo, Cindy
    Pistoia, Francesca
    Sacco, Simona
    JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
  • [22] PREDICTORS OF TOLERABILITY OF ONABOTULINUMTOXIN A INJECTION IN CHRONIC MIGRAINE: REAL-LIFE DATA AND POTENTIAL IMPLICATIONS
    Garcia-Azorin, D.
    Martinez, B.
    Ruiz-Pinero, M.
    Sierra Mencia, A.
    Guerrero Peral, A. L.
    CEPHALALGIA, 2018, 38 : 94 - 95
  • [23] CALCA GENE POLYMORPHISM INFLUENCES THERAPEUTIC RESPONSE TO ONABOTULINUMTOXIN A IN FEMALE CHRONIC MIGRAINE PATIENTS
    Moreno, R.
    Ruiz, M.
    Cernuda-Morollon, E.
    Gago, A.
    Vidriales, I.
    de la Sacristana, M. Gallego
    Pascual, J.
    Telleria, J. J.
    Guerrero, A. L.
    CEPHALALGIA, 2016, 36 : 80 - 80
  • [24] IRON DEPOSITS IN PERIAQUEDUCTAL GRAY MATTER ARE RELATED WITH POOR RESPONSE TO ONABOTULINUMTOXIN A IN CHRONIC MIGRAINE
    Dominguez, C.
    Saavedra, M.
    Rodriguez-Osorio, X.
    Villalba, C.
    Ramos-Cabrer, P.
    Sobrino, T.
    Campos, F.
    Castillo, J.
    Leira, R.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [25] Type of pain and onabotulinumtoxin-A in chronic migraine: four years of follow-up
    Cesaretti, Chiara
    Molesti, Elisabetta
    Lolli, Francesco
    Amantini, Aldo
    Lori, Silvia
    JOURNAL OF HEADACHE AND PAIN, 2015, 16 : 1 - 2
  • [26] Onabotulinumtoxin A (ONA-BoNT/A) in the treatment of chronic migraine
    Domitrz, Izabela
    Slawek, Jaroslaw
    Slowik, Agnieszka
    Boczarska-Jedynak, Magdalena
    Stepien, Adam
    Rejdak, Konrad
    Gierczynski, Jakub
    Rozniecki, Jacek
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2022, 56 (01) : 39 - 47
  • [27] Onabotulinumtoxin-A treatment in Greek patients with chronic migraine
    Vikelis, Michail
    Argyriou, Andreas A.
    Dermitzakis, Emmanouil V.
    Spingos, Konstantinos C.
    Mitsikostas, Dimos D.
    JOURNAL OF HEADACHE AND PAIN, 2016, 17
  • [28] Onabotulinumtoxin a Injection in Chronic Migraine and Patient Reported Outcomes
    Maasumi, K.
    Kriegler, J.
    Tepper, S. J.
    Thompson, N.
    HEADACHE, 2015, 55 : 142 - 143
  • [29] Onabotulinumtoxin A improves psychological aspects in chronic migraine patients
    Ashkanani, Hasan
    Ahmed, Samar
    Almutairi, Ohood
    Bokubar, Fajer
    Mubarak, Shahad
    Alwazzan, Sawsan
    Alroughani, Raed
    Al-Hashel, Jasem
    Youssry, Doaa
    NEUROLOGY, 2020, 94 (15)
  • [30] Onabotulinumtoxin-A in chronic refractory migraine: a pilot study
    Bartkova, A.
    Otruba, P.
    Sladkova, V.
    Zapletalova, J.
    Hlustik, P.
    Kanovsky, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 637 - 637
12345